Healthcare Costs & Access

Health-care pricing, access, provider rules, and delivery-system reform not specific to a program.

113 events unlock with a free account

39 grant announcements74 rulemakings this week

Create free account →

July 2026

Press releases

Press release · Department of Labor · Jul 22DOL

US Department of Labor proposes rule to modernize electronic delivery for group health plans, lowering costs

Rulemaking

Comment period closing · Food and Drug Administration · Jul 22FDAClosed

Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List

Notice · Environmental Protection Agency · Jul 22EPA

AR-226-0022 - Addendum Epidemiology Protocol: An Epidemiologic Analysis of the Inpatient and Outpatient Claims Event and Episode Experience of 3M Decatur Employees, 1993-1998

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: James Badman, Mesa, AZ; Permit No. PER33159692

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: Nicholas Austin Hardin, Houston, TX; Permit No. PER33006943

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: Mathew Olsen, Victoria, TX; Permit No. PER33005203

Notice · Food and Drug Administration · Jul 22FDA

Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Rasuvo (Methotrexate) Solution, 27.5 Milligrams/0.55 Milliliter (27.5 Milligrams/0.55 Milliliter)

Notice · Food and Drug Administration · Jul 22FDA

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notifications Submission

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021254 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021527 - Draft Guidance on Ipratropium Bromide

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_203214 - Draft Guidance on Tofacitinib Citrate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_205739 - Draft Guidance on Patiromer Sorbitex Calcium

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_022518 - Draft Guidance on Formoterol Fumarate; Mometasone Furoate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021395 - Draft Guidance on Tiotropium Bromide

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_210115 - Draft Guidance on Tacrolimus

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_009218-Sol - Draft Guidance on Warfarin Sodium

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021433 - Draft Guidance on Fluticasone Propionate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_212801 - Draft Guidance on Osilodrostat Phosphate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_019561 - Draft Guidance on Potassium Chloride

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_022008 - Draft Guidance on Ropinirole Hydrochloride

Upcoming deadlines

Medical Monitoring Project (MMP)

CDC · Comment closes · Sep 15

Medicare and Medicaid Programs: Calendar Year 2027 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

CMS · Comment closes · Sep 15

Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Voluntary Improvement Program

FDA · Comment closes · Sep 16

Medicare Program: Inflation Reduction Act of 2022 Medicare Drug Price Negotiation Program Draft Guidance

CMS · Comment closes · Sep 19

The In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems Survey Mode Experiment (CMS-10105)

CMS · Comment closes · Sep 22

46–50 of 57

Browse the document archive